title: Differentiation of pathogenic Entamoeba histolytica infections from nonpathogenic infections by detection of galactose-inhibitable adherence protein antigen in sera and feces.
abstract: We determined whether epitope-specific monoclonal antibodies to the galactose-inhibitable adherence protein (GIAP) of Entamoeba histolytica could be used in an enzyme-linked immunosorbent assay (ELISA) to detect antigen in serum and feces and differentiate between nonpathogenic zymodemes and the potentially invasive pathogenic organisms that require treatment. Overall, 57% of subjects from Cairo, Egypt, with symptomatic intestinal amebiasis and 42% with asymptomatic infection possessed GIAP antigen in their sera, whereas 4% of uninfected controls or subjects with other parasitic infections possessed GIAP antigen in their sera (P < 0.001). In subjects from Durban, South Africa, only 6% of uninfected controls or those with nonpathogenic E. histolytica infection were positive for GIAP in serum, whereas 3 of 4 with asymptomatic pathogenic intestinal infection and 75% with amebic liver abscess were positive for GIAP in serum. Fifteen stool samples from patients with intestinal amebiasis were available for study; all had a positive ELISA result for fecal GIAP antigen. Epitope-specific monoclonal antibodies identified 8 of 15 subjects with fecal antigen from pathogenic strains. Seven of those eight subjects had adherence protein antigen in their sera, whereas none of seven with apparent nonpathogenic E. histolytica infection had adherence protein antigen in their sera. In summary, we were able to detect E. histolytica adherence protein antigen directly in serum and fecal samples by ELISA. The presence of amebic antigen in serum demonstrated 94% specificity for pathogenic E. histolytica infection, and amebic antigen is present during asymptomatic intestinal infection. In conjunction with antibody detection, this method should be very useful in the diagnosis and management of intestinal amebiasis.
authors.affiliation: El-Hussein University Hospital, Cairo, Egypt.
authors.forename: M D
authors.initials: MD
authors.lastname: Abd-Alla
authors.forename: T F
authors.initials: TF
authors.lastname: Jackson
authors.forename: V
authors.initials: V
authors.lastname: Gathiram
authors.forename: A M
authors.initials: AM
authors.lastname: el-Hawey
authors.forename: J I
authors.initials: JI
authors.lastname: Ravdin
mesh_terms: D000818:Animals; D000953:Antigens, Protozoan / Q000032:analysis* / Q000097:blood; D000954:Antigens, Surface / Q000032:analysis* / Q000097:blood; D004748:Entamoeba histolytica / Q000276:immunology*; D004749:Entamoebiasis / Q000175:diagnosis*; D004797:Enzyme-Linked Immunosorbent Assay; D005243:Feces / Q000469:parasitology*; D005690:Galactose / Q000037:antagonists & inhibitors; D006801:Humans; D051379:Mice
chemical_list: D000953:Antigens, Protozoan; D000954:Antigens, Surface; D005690:Galactose